Inovio Pharmaceuticals

Inovio Pharmaceuticals is a company listed under the stock ticker INO (US).

View the org chart displaying its 23 main executives

Most searched biographies at Inovio Pharmaceuticals

• Jacqueline Shea, President and Chief Executive Officer
• Wendy Yarno, Director
• Ann Miller, Director

Create your alert
to follow the executive moves at Inovio Pharmaceuticals.

Inovio Pharmaceuticals has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Inovio Pharmaceuticals

• INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
• INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
• INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
• INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
• INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
• INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
• INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
• INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
• INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
• INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
• View more press releases Close

Social media about Inovio Pharmaceuticals

• Inovio Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Inovio Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Simon Benito

Call Inovio Pharmaceuticals at +1 267...

View the org chart

Register to receive your alert

Report an error